国际浆膜腔积液细胞病理报告系统在脑脊液细胞学中的应用:诊断分类与总生存期的关联分析
本研究将国际浆膜腔积液细胞病理报告系统(TIS)分类应用于三个学术中心2019至2022年的1137例脑脊液标本,回顾性分析诊断分类与总生存期(OS)的关联。579例有随访患者中,OS在各诊断类别间差异显著(p < .001),从阴性/意义不明的异型性到可疑恶性/恶性呈明显下降趋势,支持TIS作为脑脊液细胞病理学的标准化风险分层框架。
要点
- TIS分类可用于脑脊液细胞学,各诊断类别与总生存期显著相关(p < .001)。
- 恶性类别患者平均生存期最短(18.7个月),阴性类别最长(53.9个月)。
- TIS为脑脊液细胞病理提供标准化报告框架,有助于风险分层和临床决策。
核心结论
- TIS分类可有效将脑脊液标本分层为不同预后组,诊断分类与总生存期显著相关,支持其作为脑脊液细胞病理学的标准化循证框架。
研究设计与样本
- 回顾性多中心队列研究,纳入三个学术中心(两大洲)2019至2022年病理数据库的1137例脑脊液细胞学标本,按TIS标准重新分类,采用Kaplan-Meier曲线和Cox比例风险模型分析总生存期,多变量分析用于死亡预测因素。
主要发现
- 诊断分布为:无诊断意义3.2%、恶性阴性67.1%、意义不明的异型性6.2%、可疑恶性2.7%、恶性20.8%。
- 579例有随访患者中,各诊断类别间OS差异显著(p < .001)。
- 平均生存期:恶性阴性53.9个月,意义不明的异型性48.4个月,可疑恶性40.3个月,恶性18.7个月。
关键数值与推荐
- TIS诊断类别:无诊断意义、恶性阴性、意义不明的异型性、可疑恶性、恶性。
- 各诊断类别平均生存期分别为53.9、48.4、40.3和18.7个月(恶性阴性、意义不明的异型性、可疑恶性、恶性),组间OS差异p < .001。
临床怎么用
- 在脑脊液细胞学报告中采用TIS五分类标准,可提供与生存预后相关的分层信息,辅助临床风险沟通与决策。
局限性
- 回顾性设计,仅579例(约半数)患者有随访数据,可能引入选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cerebrospinal fluid (CSF) cytopathology lacks standardized reporting, leading to diagnostic variability and inconsistent clinical management. Although the International System for Reporting Serous Fluid Cytopathology (TIS) has been established for effusions, its utility in CSF remains underexplored. For this study, the authors applied TIS categories to CSF specimens from three academic centers across two continents and evaluated their association with overall survival (OS). METHODS: A retrospective review of pathology databases (2019-2022) across three institutions was performed. Data included demographics, cytologic diagnosis, and OS. Diagnoses were reclassified using TIS criteria. OS was analyzed using Kaplan-Meier curves and Cox proportional hazards models, and multivariable analysis was used for predictors of mortality. RESULTS: In total, 1137 patients underwent CSF cytologic evaluation. Diagnostic distribution was as follows: 3.2% nondiagnostic, 67.1% negative for malignancy, 6.2% atypia of undetermined significance, 2.7% suspicious for malignancy, and 20.8% malignant. Among 579 patients with follow-up, OS differed across categories (p < .001). Mean survival was longest in patients who were diagnosed as negative for malignancy (53.9 months), followed by atypia of undetermined significance (48.4 months), and suspicious for malignancy (40.3 months), and it was shortest in patients who were diagnosed with malignancy (18.7 months). CONCLUSIONS: Leveraging a large, multi-institutional cohort with up to 5 years of follow-up, this study demonstrated that TIS categories effectively stratify CSF specimens into distinct prognostic groups. The authors identified a significant correlation between diagnostic classification and OS, with a clear decline in patient outcomes from those who had diagnoses of negative for malignancy/atypia of undetermined significance to those who had diagnoses of suspicious for malignancy and malignancy. These findings support the TIS system as a standardized, evidence-based framework that enhances risk stratification and clinical decision-making in CSF cytopathology.
引用
- Yildiz Aktas IZ, Chakraborty B, Zhang JM, et al. Application of the International System for Serous Fluid Cytopathology in cerebrospinal fluid cytology: Overall survival analysis associated with diagnostic categories. Cancer Cytopathol. 2026. PMID: 42324785. doi:10.1002/cncy.70127
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。